Article Information
History
- November 30, 2021.
Article Versions
- Version 1 (November 5, 2021 - 08:04).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brenna C Novotny1,2,3,*,
- Maria Victoria Fernandez1,2,3,*,
- Ciyang Wang1,2,3,4,
- John P Budde1,2,3,
- Kristy Bergmann1,2,3,
- Abdallah Eteleeb1,2,3,
- Joseph Bradley4,
- Carol Webster1,2,3,
- Curtis Ebl1,2,3,
- Joanne Norton1,2,3,
- Jen Gentsch1,2,3,
- Umber Dube1,
- Fengxian Wang1,2,3,
- John C Morris2,5,6,
- Randall J Bateman2,5,6,
- Richard J Perrin2,5,6,7,
- Eric McDade6,
- Chengjie Xiong5,
- Jasmeer Chhatwal8,
- Dominantly Inherited Alzheimer Network Study Group,
- Alzheimer’s Disease Neuroimaging Initiative9,
- Alzheimer’s Disease Metabolomics Consortium10,
- Alison Goate11,
- Martin Farlow12,
- Peter Schofield13,
- Helena Chui14,
- Celeste M Karch1,2,3,
- Bruno A Benitez1,2,3,†,
- Carlos Cruchaga1,2,3,5,† and
- Oscar Harari1,2,3,5,†,‡
- 1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
- 2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
- 3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
- 4Division of Biology & Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA
- 5The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
- 6Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA
- 7Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
- 8Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- 11Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 12Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
- 13Neuroscience Research Australia, Randwick, Sydney, NSW, Australia
- 14Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
- ↵‡Corresponding author Oscar Harari, PhD, Assistant Professor, Dept. of Psychiatry. Washington University, School of Medicine, 4444 Forest Park Ave. Office 5587 - Campus Box 8134, St. Louis, MO, 63110, T: (314) 273-1862, Email: harario{at}wustl.edu
↵9 Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
↵* These authors contributed equally as first authors
↵† These authors contributed equally as senior authors
Posted November 30, 2021.
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains
